BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 3540244)

  • 41. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal antibody Leu-22 (L60) permits the demonstration of some neoplastic T cells in routinely fixed and paraffin-embedded tissue sections.
    Wieczorek R; Buck D; Bindl J; Knowles DM
    Hum Pathol; 1988 Dec; 19(12):1434-43. PubMed ID: 2973429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen.
    Salter DM; Krajewski AS; Dewar AE
    J Pathol; 1985 Aug; 146(4):345-53. PubMed ID: 2411901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
    Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
    Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies reactive with normal and neoplastic T cells in paraffin sections.
    Ng CS; Chan JK; Hui PK; Lo ST
    Hum Pathol; 1988 Mar; 19(3):295-303. PubMed ID: 3278967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
    Warnke RA; Weiss LM
    Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
    Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
    Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope.
    Schwarting R; Gerdes J; Dürkop H; Falini B; Pileri S; Stein H
    Blood; 1989 Oct; 74(5):1678-89. PubMed ID: 2477085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective binding of peanut lectin by T lineage lymphocytes in paraffin sections.
    Codegone ML; Bussolati G; Spinnato MR; Stramignoni A
    Basic Appl Histochem; 1983; 27(3):177-82. PubMed ID: 6605747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of plasmacytoid T cells in lymphoid hyperplasia of the skin.
    Eckert F; Schmid U
    Arch Dermatol; 1989 Nov; 125(11):1518-24. PubMed ID: 2817916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunohistologic investigations of paraffin-embedded lymph nodes after bone marrow transplantation in autopsy samples].
    Friedrich T; Kupper H; Püschel W; Pönisch W; Helbig W
    Verh Dtsch Ges Pathol; 1991; 75():136-40. PubMed ID: 1724816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD1c antigens are present in normal and neoplastic B-cells.
    Smith ME; Thomas JA; Bodmer WF
    J Pathol; 1988 Oct; 156(2):169-77. PubMed ID: 3264333
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods in pathology. Immunophenotype of hairy cell leukemia in paraffin sections.
    Strickler JG; Schmidt CM; Wick MR
    Mod Pathol; 1990 Jul; 3(4):518-23. PubMed ID: 2217156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.